loading
前日終値:
$16.26
開ける:
$16.45
24時間の取引高:
71,316
Relative Volume:
0.08
時価総額:
$1.80B
収益:
$14.09M
当期純損益:
$-176.94M
株価収益率:
-7.698
EPS:
-2.15
ネットキャッシュフロー:
$-141.24M
1週間 パフォーマンス:
+2.93%
1か月 パフォーマンス:
-30.75%
6か月 パフォーマンス:
-12.63%
1年 パフォーマンス:
-18.29%
1日の値動き範囲:
Value
$16.20
$17.33
1週間の範囲:
Value
$15.72
$17.33
52週間の値動き範囲:
Value
$14.06
$27.29

Newamsterdam Pharma Company Nv Stock (NAMS) Company Profile

Name
名前
Newamsterdam Pharma Company Nv
Name
セクター
Healthcare (1155)
Name
電話
35 206 2971
Name
住所
GOOIMEER 2-35, NARRDEN
Name
職員
68
Name
Twitter
Name
次回の収益日
Name
最新のSEC提出書
Name
NAMS's Discussions on Twitter

NAMS を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
NAMS
Newamsterdam Pharma Company Nv
16.56 1.80B 14.09M -176.94M -141.24M -2.15
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
488.45 127.47B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
577.56 62.43B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
599.40 37.03B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
232.44 31.06B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
248.37 26.16B 3.81B -644.79M -669.77M -6.24

Newamsterdam Pharma Company Nv Stock (NAMS) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-12-30 開始されました H.C. Wainwright Buy
2024-05-15 開始されました TD Cowen Buy
2024-03-14 開始されました Scotiabank Sector Outperform
2024-01-18 開始されました Guggenheim Buy
2024-01-16 開始されました Piper Sandler Overweight
2023-10-30 開始されました RBC Capital Mkts Outperform
すべてを表示

Newamsterdam Pharma Company Nv (NAMS) 最新ニュース

pulisher
12:52 PM

11 Best Guru Stocks to Buy According to Wall Street Analysts - Insider Monkey

12:52 PM
pulisher
Apr 21, 2025

Head to Head Survey: NewAmsterdam Pharma (NASDAQ:NAMS) vs. Cyclerion Therapeutics (NASDAQ:CYCN) - Defense World

Apr 21, 2025
pulisher
Apr 18, 2025

Is NewAmsterdam Pharma Company NV (NASDAQ: NAMS) A Good Investment Now? - Stocksregister

Apr 18, 2025
pulisher
Apr 18, 2025

Newamsterdam pharma COO Douglas Kling sells $1.65 million in shares By Investing.com - Investing.com Canada

Apr 18, 2025
pulisher
Apr 17, 2025

NewAmsterdam Pharma adds Adele Gulfo to its Board By Investing.com - Investing.com South Africa

Apr 17, 2025
pulisher
Apr 17, 2025

Newamsterdam pharma COO Douglas Kling sells $1.65 million in shares - Investing.com Australia

Apr 17, 2025
pulisher
Apr 17, 2025

NewAmsterdam Pharma adds Adele Gulfo to its Board - Investing.com

Apr 17, 2025
pulisher
Apr 17, 2025

NewAmsterdam Pharma Appoints Adele Gulfo to its Board of Directors - GlobeNewswire

Apr 17, 2025
pulisher
Apr 17, 2025

NewAmsterdam Pharma Company N.V. Appoints Adele Gulfo to its Board of Directors - marketscreener.com

Apr 17, 2025
pulisher
Apr 13, 2025

Arrowstreet Capital Limited Partnership Acquires New Shares in NewAmsterdam Pharma (NASDAQ:NAMS) - Defense World

Apr 13, 2025
pulisher
Apr 12, 2025

Sei Investments Co. Sells 14,456 Shares of NewAmsterdam Pharma (NASDAQ:NAMS) - Defense World

Apr 12, 2025
pulisher
Apr 11, 2025

NewAmsterdam Pharma (NAMS): Among Billionaire Stanley Druckenmiller’s Top Stock Picks with Huge Upside Potential - Insider Monkey

Apr 11, 2025
pulisher
Apr 09, 2025

KLP Kapitalforvaltning AS Purchases Shares of 6,000 NewAmsterdam Pharma (NASDAQ:NAMS) - Defense World

Apr 09, 2025
pulisher
Apr 08, 2025

The Analyst Verdict: NewAmsterdam Pharma Co In The Eyes Of 6 Experts - Benzinga

Apr 08, 2025
pulisher
Apr 08, 2025

NewAmsterdam Pharma (NASDAQ:NAMS) Sets New 52-Week Low – Here’s Why - Defense World

Apr 08, 2025
pulisher
Apr 08, 2025

NewAmsterdam Pharma (NASDAQ:NAMS) Receives $43.33 Average Price Target from Analysts - Defense World

Apr 08, 2025
pulisher
Apr 07, 2025

Where are the Opportunities in (NAMSW) - news.stocktradersdaily.com

Apr 07, 2025
pulisher
Apr 04, 2025

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Apr 04, 2025
pulisher
Apr 04, 2025

NewAmsterdam Pharma Expands Team: 133,000 Shares Granted to Strategic New Hires - Stock Titan

Apr 04, 2025
pulisher
Apr 04, 2025

NewAmsterdam Pharma to Participate in Upcoming Investor Conferences in September - MarketScreener

Apr 04, 2025
pulisher
Apr 03, 2025

American Century Companies Inc. Acquires Shares of 346,572 NewAmsterdam Pharma (NASDAQ:NAMS) - Defense World

Apr 03, 2025
pulisher
Apr 02, 2025

Teacher Retirement System of Texas Makes New $276,000 Investment in NewAmsterdam Pharma (NASDAQ:NAMS) - Defense World

Apr 02, 2025
pulisher
Apr 01, 2025

When (NAMS) Moves Investors should Listen - news.stocktradersdaily.com

Apr 01, 2025
pulisher
Mar 31, 2025

NewAmsterdam Pharma to Present at the 24th Annual Needham Virtual Healthcare Conference - GlobeNewswire

Mar 31, 2025
pulisher
Mar 31, 2025

Leading Cardiovascular Drug Developer NewAmsterdam Sets Key Investor Presentation - Stock Titan

Mar 31, 2025
pulisher
Mar 29, 2025

Newamsterdam Pharma CEO Michael Davidson sells shares for $281,000 By Investing.com - Investing.com Australia

Mar 29, 2025
pulisher
Mar 29, 2025

Newamsterdam Pharma director James Topper buys $25,520 in shares - Investing.com Australia

Mar 29, 2025
pulisher
Mar 29, 2025

NewAmsterdam Pharma (NASDAQ:NAMS) Shares Acquired by Swiss National Bank - Defense World

Mar 29, 2025
pulisher
Mar 28, 2025

Newamsterdam pharma COO sells shares worth $376,000 By Investing.com - Investing.com Canada

Mar 28, 2025
pulisher
Mar 28, 2025

Newamsterdam Pharma director James Topper buys $25,520 in shares By Investing.com - Investing.com South Africa

Mar 28, 2025
pulisher
Mar 28, 2025

Newamsterdam Pharma CEO Michael Davidson sells shares for $281,000 - Investing.com India

Mar 28, 2025
pulisher
Mar 28, 2025

Newamsterdam pharma COO sells shares worth $376,000 - Investing.com India

Mar 28, 2025
pulisher
Mar 19, 2025

Newamsterdam Pharma COO Kling sells $2.36 million in stock By Investing.com - Investing.com Australia

Mar 19, 2025
pulisher
Mar 19, 2025

Newamsterdam Pharma COO Kling sells $2.36 million in stock - Investing.com

Mar 19, 2025
pulisher
Mar 18, 2025

NewAmsterdam Pharma (NASDAQ:NAMS) Shares Sold by US Bancorp DE - Defense World

Mar 18, 2025
pulisher
Mar 14, 2025

NewAmsterdam Pharma (NASDAQ:NAMS) Receives $43.33 Consensus Price Target from Analysts - Defense World

Mar 14, 2025
pulisher
Mar 12, 2025

Financial Metrics Exploration: Understanding NewAmsterdam Pharma Company NV (NAMS) Through Ratios - The Dwinnex

Mar 12, 2025
pulisher
Mar 12, 2025

9,983 Shares in NewAmsterdam Pharma (NASDAQ:NAMS) Purchased by Keybank National Association OH - Defense World

Mar 12, 2025
pulisher
Mar 11, 2025

(NAMS) Trading Advice - news.stocktradersdaily.com

Mar 11, 2025
pulisher
Mar 10, 2025

A better buy-in window may exist right now for NewAmsterdam Pharma Company NV (NAMS) - SETE News

Mar 10, 2025
pulisher
Mar 07, 2025

Newamsterdam pharma director James Topper buys $84,203 in shares By Investing.com - Investing.com Australia

Mar 07, 2025
pulisher
Mar 06, 2025

Newamsterdam pharma director James Topper buys $84,203 in shares - Investing.com

Mar 06, 2025

Newamsterdam Pharma Company Nv (NAMS) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$19.80
price down icon 1.75%
$70.30
price up icon 2.22%
$32.51
price up icon 0.87%
$26.24
price up icon 1.84%
$102.53
price down icon 0.01%
biotechnology ONC
$248.35
price up icon 8.46%
大文字化:     |  ボリューム (24 時間):